Hisamitsu Pharmaceutical Co., Inc.

HTSUY · OTC
Analyze with AI
2/28/2025
2/28/2024
2/28/2023
2/28/2022
Operating Activities
Net Income$143$19,186$88$87
Dep. & Amort.$42$5,172$37$39
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$46-$1,227-$10$35
Other Non-Cash-$15-$4,943-$20$12
Operating Cash Flow$123$18,188$95$172
Investing Activities
PP&E Inv.-$90-$13,036-$59-$38
Net Acquisitions$1-$6,800$7$0
Inv. Purchases-$3-$15-$141-$102
Inv. Sales/Matur.$208$1,552$15$22
Other Inv. Act.$0$15,787$0$0
Investing Cash Flow$115-$2,512-$178-$117
Financing Activities
Debt Repay.$11-$70-$71-$117
Stock Issued$0$0-$0-$0
Stock Repurch.-$69-$9,796-$7,694-$8,043
Dividends Paid-$43-$6,578-$50-$61
Other Fin. Act.-$3-$247$7,706$8,085
Financing Cash Flow-$104-$16,691-$109-$136
Forex Effect$4$1,957-$76-$27
Net Chg. in Cash$139$942-$269-$109
Supplemental Information
Beg. Cash$360$65,424$749$857
End Cash$499$66,366$480$749
Free Cash Flow$34$5,152$36$135